Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tenon Medical (TNON) EBIT Margin (2021 - 2025)

Historic EBIT Margin for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to 289.17%.

  • Tenon Medical's EBIT Margin rose 732800.0% to 289.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 405.17%, marking a year-over-year increase of 91300.0%. This contributed to the annual value of 420.08% for FY2024, which is 1170400.0% up from last year.
  • As of Q3 2025, Tenon Medical's EBIT Margin stood at 289.17%, which was up 732800.0% from 506.56% recorded in Q2 2025.
  • In the past 5 years, Tenon Medical's EBIT Margin registered a high of 289.17% during Q3 2025, and its lowest value of 7331.82% during Q2 2021.
  • Over the past 5 years, Tenon Medical's median EBIT Margin value was 581.7% (recorded in 2023), while the average stood at 1751.17%.
  • In the last 5 years, Tenon Medical's EBIT Margin plummeted by -16681700bps in 2022 and then skyrocketed by 34597900bps in 2023.
  • Tenon Medical's EBIT Margin (Quarter) stood at 4833.96% in 2021, then surged by 41bps to 2862.09% in 2022, then surged by 86bps to 388.74% in 2023, then fell by -6bps to 412.08% in 2024, then grew by 30bps to 289.17% in 2025.
  • Its EBIT Margin stands at 289.17% for Q3 2025, versus 506.56% for Q2 2025 and 506.47% for Q1 2025.